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Staphylococcus aureus (S. aureus) strains with multiple antibiotic resistances are increasingly widespread, and new agents are
required for the treatment of S. aureus. Cryptotanshinone (CT), a major tanshinone of medicinal plant Salvia miltiorrhiza
Bunge, demonstrated eﬀective in vitro antibacterial activity against all 21 S. aureus strains tested in this experiment. Aﬀymetrix
GeneChipswereutilizedtodeterminetheglobaltranscriptionalresponseofS.aureusATCC25923totreatmentwithsubinhibitory
concentrations of CT. Transcriptome proﬁling indicated that the antibacterial action of CT may be associated with its action as
active oxygen radical generator; S. aureus undergoes an oxygen-limiting state upon exposure to CT.
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1.Introduction
Staphylococcus aureus (S. aureus) is one of the most impor-
tant pathogens in both hospitals and the community and can
cause numerous syndromes in humans, such as endocarditis,
osteomyelitis, and septicemia [1, 2]. Greater than 60% of S.
aureus isolates are now resistant to methicillin (oxacillin),
and some strains have developed resistance to more than 20
diﬀerent antimicrobial agents [3]; new agents are therefore
needed for the treatment of S. aureus.
For over 100 years, chemical compounds isolated from
medicinal plants have served as the models for many
clinically proven drugs and are now being reassessed as
antimicrobial agents [4]. Cryptotanshinone (CT) is a major
tanshinone of Dan Shen, the root of Salvia miltiorrhiza
Bunge (Labiatae) [5]. CT exhibits antimicrobial activity
against a broad range of Gram-positive, including S. aureus,
and Gram-negative bacteria as well as other microorganisms
[6, 7].
Although CT exhibited fairly high levels of activity
against S. aureus, there have been no reports related to
the inhibitory mechanisms of CT against S. aureus.T r a n -
scriptional proﬁlings generated with Aﬀymetrix GeneChips
have been used to identify genes of S. aureus that were
induced in response to the antibiotics vancomycin, oxacillin,
d-cycloserine, or bacitracin [8, 9]. Transcriptional proﬁles
of microorganisms treated with an inhibitor could provide
valuable information for both pathway characterization, and
for determination of the mechanism of inhibition [10, 11].
In this report, toinvestigate theantimicrobial activity and
the possible action mechanisms of CT against S. aureus,w e
testedtheminimuminhibitory concentrations(MICs)ofCT
against 21 S. aureus strains, as well as utilizing Aﬀymetrix
GeneChip analysis to identify diﬀerentially expressed genes
for S. aureus treated with subinhibitory concentrations of
CT.
2.MaterialsandMethods
2.1. Bacterial Strains and Materials. The S. aureus strains
used in this study were comprised of 20 clinical iso-
lates from the First Hospital of Jilin University, which
have diﬀerent antibiograms against 12 antimicrobial agents
(Table 1), and the standard strain ATCC 25923 obtained2 Journal of Biomedicine and Biotechnology
from China Medical Culture Collection Center (CMCC).
Mueller-Hinton broth II (MHB II) and Mueller-Hinton agar
(MHA) were purchased from BD (Biosciences, Inc., Sparks,
Md). CT was purchased from the China Medical Culture
Collection Centre (CMCC), and stock solutions of varying
concentrations were dissolved in dimethyl sulfoxide (DMSO,
Sigma-Aldrich).
2.2. Antibiotic Susceptibility Testing. The minimum inhibi-
tion concentrations (MICs) of CT against the 21 S. aureus
strains were determined in triplicate by broth microdilution
or broth macrodilution using twofold serial dilutions in
MHB II, according to CLSI/NCCLS M100-S15. The MICs
were deﬁned as the lowest concentration at which no visible
growth was observed. The minimum concentration of CT
that inhibited 90% of the isolates tested was deﬁned as the
MIC90.
2.3. Synergistic Study. A standard checkerboard assay was
performed to assess the interaction of combination (CT
and TMP/SXT) against S. aureus strain ATCC 25923 by
a well-established method [12]. The fractional inhibitory
concentration (FIC) index was calculated by a previously
described method [12]. An FIC index (FICI) between two
compounds less than or equal to 0.5 is considered synergism,
an FIC index between 0.5 and 2 is considered indiﬀerence,
andaFICIequaltoormorethan2isconsideredantagonism.
2.4. Growth Curves. S. aureus strain ATCC 25923 was grown
to an optical density of 0.3 at 600nm in MHB II, and
100mL aliquots were then distributed into ﬁve 500mL
Erlenmeyer ﬂasks. CT (dissolved in DMSO) was added to
four of the cultures to obtain ﬁnal concentrations of 1/4 ×
MIC (1μg·mL), 1/2 × MIC (2μg·mL), MIC (4μg·mL), and
2 × MIC (8μg·mL), respectively. The ﬁnal DMSO concen-
tration used was 1% (vol/vol), and the control culture was
supplemented with 1% DMSO. The cultures were incubated,
andcellgrowthwasspectrophotometricallymonitoredasthe
optical density at600nm, whichwasrecordedatcertaintime
intervals.
2.5. Treatment with CT. S. aureus strain ATCC 25923 was
grown overnight at 200rpm in a rotary shaker at 37◦C
in 10mL of MHB II. Six 250-mL Erlenmeyer ﬂasks, each
containing 100mL of MHB II, were inoculated with an
overnight culture to an initial OD600 of 0.05. The bacteria
were then grown at 37◦C at 200rpm to an OD600 of 0.3.
Subsequently, 500μL of a 12800μg·mL CT stock solution,
prepared in dimethyl sulfoxide (DMSO), was added to three
of the cultures (experimental cultures), yielding a ﬁnal
concentration of 1/2 × MIC (2μg·mL). Hence, the ﬁnal
concentration of solvent in each CT treatment was 1%
(vol/vol) DMSO, which did not alter the pH of the medium.
The other three cultures lacking CT and supplemented with
1% (vol/vol) DMSO were used as the control. All bacterial
suspensions (both CT treatment or control condition)
were further incubated for 30 minutes at 37◦Cf o rR N A
isolation.
2.6. RNA Isolation and cDNA Labeling. Bacterial cells were
treated with RNA Protect bacterial reagent (QIAGEN, Inc.,
Valencia, Calif) to minimize RNA degradation immediately
before harvesting. Cells were collected by centrifugation and
stored at −80◦C. RNA isolation and cDNA labeling were
performed as previously described [13]. Three independent
RNA preparations and cDNA labelings were performed on
diﬀerent days.
2.7. GeneChip Hybridization and Analysis. The GeneChip S.
aureus genome array (antisense) was provided by CapitalBio
Corporation (http://www.capitalbio.com/index.asp, Beijing,
China), a service provider authorized by Aﬀymetrix Inc.
(Santa Clara, CA). This GeneChip includes N315, Mu50,
NCTC 8325, and COL. The array contains probe sets to
over 3300 S. aureus ORFs and over 4800 intergenic regions.
GeneChip hybridization, washing, staining, and scanning
were performed as previously described [13].
The images were processed with Microarray Analysis
Suite 5.0 (Aﬀymetrix). The raw data from the array scans
were normalized by median-centering genes for each array,
followed by log transformation. Expressed genes were identi-
ﬁed using Aﬀymetrix GeneChip Operating Software (GCOS,
Ver.1.0), which utilizes statistical criteria to generate a
“present”or“absent”callforgenesrepresentedbyeachprobe
setonthearray.Additionally,geneswith“absent”scoreswere
ﬁltered out of the dataset, and the remaining genes were
analyzed. To identify genes that are diﬀerentially expressed
in CT-treated samples compared to controls, the Signiﬁ-
cance Analysis of Microarrays (SAM) software (http://www-
stat.stanford.edu/∼tibs/SAM/index.html)wasused.Toselect
the diﬀerentially expressed genes, we used threshold values
of ≥1.5- and ≤–1.5-fold change between three RH treatment
samplesandthreecontrolsamples;theFDRsigniﬁcancelevel
was <5%.
2.8. Quantitative Real-Time RT-PCR. Quantitative real-time
reverse transcription (RT)-PCR was used to verify the
microarray results. Aliquots of the RNA preparations from
CT-treated and control samples used in the microarray
experiments were also used for quantitative real-time RT-
PCRfollow-upstudies.ThecDNAwassubjectedtoreal-time
PCR using the primer pairs listed in Table 2. Quantitative
real-time PCR was performed in triplicate using the 7000
SequenceDetectionSystem(AppliedBiosystems,FosterCity,
CA, USA), as previously described [13].
3. Results and Discussion
3.1. MICs of CT Against S. aureus Strains and Inﬂuence of
CT on Growth Curves. In this experiment, the MICs of CT
against 21 S. aureus strains ranged from 4 to 64μg·mL
(Table 1), and the MIC90 was 16μg·mL. The MIC value of S.
aureusstrainATCC25923versusCTwas4μg·mL.Thisresult
demonstrated that CT is a potentially eﬀective antimicrobial
against S. aureus.
We performed growth curve of S. aureus ATCC 25923
w i t hC T( 1 ,2 ,4 ,8 ,a n d1 6 μg·mL) added at the timeJournal of Biomedicine and Biotechnology 3
Table 1: Antibiograms of 21 Staphylococcus aureus strains used in this study.
Strains Source Date of isolation Antibiotic
resistances
V MIC CIP MIC OX MIC CT MIC
(mo/yr) (μg·mL) (μg·mL) (μg·mL) (μg·mL)
SA003 Blood 2/2003 P 1 0.12 0.12 4
SA006 Skin 2/2003 M, P, CI, CM, E 1 64 128 8
SA009 Skin abscess 3/2003 M, CI, CM, E 0.5 128 256 16
SA017 Skin abscess 5/2003 P, T 20 . 5 0 . 54
SA018 Broncheal swab 6/2003 M, P, CI, CM, E,
G
2 128 512 16
SA025 Sputum 10/2003 — 0.25 0.25 0.12 4
SA039 Broncheal swab 2/2004
M, P, CI, CM, E,
G, RI, T,
TMP/SXT
1 512 512 64
SA059 Broncheal swab 6/2004 M, P, CI, T,
TMX/SXT
2 128 512 8
SA079 Sputum 9/2004 M, P, CI, CM, E,
G, TMP/SXT
4 128 256 32
SA092 Abscess 10/2004 M, P, E 1 16 128 16
SA106 Wound isolate 1/2005 M, P, CI, CM, E,
G, T, TMP/SXT
0.5 256 512 16
SA118 Blood 1/2005 M, P, E, G 1 64 256 16
SA121 Wound isolate 3/2005 M, P, CM, E, G 1 128 256 16
SA142 Abscess 5/2005 P, T, E 11 0 . 5 8
SA146 Skin abscess 5/2005 M ,P ,C M ,E ,T 2 64 128 16
SA165 Urine 6/2006 P, CI, CM, E, G,
RI, T
2 256 512 16
SA173 Broncheal swab 8/2005 M, P, T 0.25 32 128 8
SA179 Blood 9/2005 M, CI, CM, E 1 128 512 16
SA192 Urine 10/2005 M, P, CI, CM, E,
G
1 64 512 16
SA203 Wound isolate 12/2005 M, P, CM, T 2 64 512 16
ATCC25923 CMCC — — 1 0.25 0.25 4
Abbreviations: M: methicillin; P: penicillin; CI: clindamycin; CM: chloramphenicol; E: erythromycin; G: gentamicin; RI: rifampin; T: tetracycline; TMP/SXT:
trimethoprimsulfamethoxazole; V: vancomycin; CIP: Ciproﬂoxacin; OX: Oxacillin.
point of OD600 = 0.3. Equivalent DMSO was added to
the experimental cultures and control cultures. Bacterial
cells samples were collected at certain time intervals in
this experiment with a time course of 1440 minutes, and
the growth curves of CT-treated and untreated strain were
measuredspectrophotometrically.With1and2μg·mLofCT
and controls, we found the optical density increased steadily,
while with 4μg·mL, 8μg·mL, and 16μg·mL of CT, we did
not observe increase in the optical density (Figure 1). This
result showed that CT displays bacteriostatic action against
S. aureus, which is consistent with previous reports [15, 16].
3.2. Gene Transcription Responses to CT Exposure. GeneChip
analysis revealed that a substantial number of genes (185)
were diﬀerentially regulated in response to CT. Of these,
100 genes exhibited a signiﬁcant increase in transcript abun-
dance, and 85 exhibited a signiﬁcant decrease in transcript
abundance. The microarray-related data were submitted
to Gene Expression Omnibus (GEO) under the accession
number:GSE13203.ThedistributionofCT-responsivegenes
and their biological roles are shown in Figure 2.Ac o m p l e t e
list of all genes diﬀerentially expressed by CT can be
found in the supplemental material (See supplementary
Table S1 in supplementary material available online at doi:
10.1155/2009/617509). Herein, our interest mainly focused
on speciﬁc genes that may allow the organism to survive in
the presence of CT.
3.3. Genes of the Sortase Enzyme and Iron-Regulated Surface
Determinants (Isd) are Inhibited in Response to CT. In the
present study, the sortase-encoding gene srtB (SA0982) was
repressed 3-fold, and some surface protein-encoding genes
of isdABDEFG were also signiﬁcantly inhibited in response
to CT. The Isd cluster of S. aureus is composed of 10
genes (isdABCDEFGHI and srtB). Pathogens, such as S.
aureus, require iron for survival and have evolved specialized
proteins, such as Isd, to scavenge heme from their host [17].
Therefore, the staphylococcal Isd system can be viewed as a
pathogenic strategy for scavenging heme iron during infec-
tion by tapping into the iron rich source of hemoproteins4 Journal of Biomedicine and Biotechnology
Table 2: Primers used in real-time RT-PCR with SYBR green probes.
Primer N315 ORF(a) Sequence
16S rRNAfor(b) SArRNA01 CGTGCTACAATGGACAATACAAA
16S rRNArev(b) SArRNA01 ATCTACGATTACTAGCGATTCCA
ribAfor SA1587 GCTTACATTCTGCGTGCCTTAC
ribArev SA1587 ACAATCCTATGCCACGACCT
isdAfor SA0977 GCAACAGCGAAATCTGAAAG
isdArev SA0977 AAGGCAACTGTGCTAATAAAG
modAfor SA2074 TTAACTATGGTGGATCAGGG
modArev SA2074 CATGCGCTTTATTCTTGTCT
seofor SA1648 AGTCAAGTGTAGACCCTATT
seorev SA1648 AGATATTCCATCTAACCAAT
SA1831for SA1831 CGTGGTTTATCAACTTGAGT
SA1831rev SA1831 TATTCTTTAATTCTTGTGCG
srtBfor SA0982 TAAATAAAGACATTGTTGGATGG
srtBrev SA0982 TACGTCGATGTTCTCGCTCA
glpTfor SA0325 CGACTTTGCTACAAGCGATAA
glpTrev SA0325 CGCCCAATCAAGTACACCA
oppFfor SA0198 TCAGAAGGCTTTATTTGGT
oppFrev SA0198 GAATGATTAGTGGTCGTTTA
SA2135for SA2135 AACTTAAAGCCTCAACATAG
SA2135rev SA2135 TAACTTCCAACTGCCATAC
msmXfor SA0206 CATTTGGGCTAAAGCTACG
msmXrev SA0206 GACGCTGTCCACCAGATAA
opp-1Ffor SA2251 TCATCATTACACCCATTTC
opp-1Frev SA2251 GCCTTAGATAGACCGACTT
dpsfor SA1941 TTAGCGGTAGGAGGAAAC
dpsrev SA1941 ATCATCGCCAGCATTACC
SA0302for SA0302 GAATGGAAAAACAGGAAAAC
SA0302rev SA0302 GCAAACACATAGCCAATAAG
(a) ORF, open reading frame.
(b)refer to references [14].
[18]. Our results suggest that CT signiﬁcantly aﬀected the
staphylococcal Isd system. In our study, the transcriptional
level of srtCHI was not diﬀerentially modulated by a factor
of ≥2.0 or ≤−2.0 upon exposure to CT.
3.4. Anaerobic Respiration and Fermentation, and Oxidative
Stress Resistance Genes Regulated by CT. The expression of
some genes involved in anaerobic respiration and fermenta-
tion was induced by CT during this study, including fdaB,
pﬂB, pﬂA, nirB, nirD, narG, narH,a n dnarI.
The fdaB gene encodes fructose-bisphosphate aldolase.
The transcription of the fdaB gene, which is involved in
glycolysis, was upregulated, indicating enhanced glycolytic
activity by CT. Similar upregulation results were obtained
for fdaB under anaerobic conditions [19]. The pﬂB andpﬂA
genes encode enzymes of the fermentation pathways, which
are involved in acetate and ethanol formation [19]. Prior
studies demonstrated that the pﬂA/pﬂB pair is involved in
energymetabolismwhenE.coligrowsunderoxygen-limiting
conditions [20]. NarG (respiratory nitrate reductase, alpha
subunit), NarH (respiratory nitrate reductase, beta subunit),
and NarI (respiratory nitrate reductase, gamma subunit)
have been shown to be involved in nitrate respiration in E.
coli [21]. NirB (nitrite reductase, large subunit) and NirD
(nitrite reductase, small subunit) are essential and suﬃcient
for NADH-dependent nitrite reduction [22]. Furthermore,
S.aureusisabletousenitrateornitrite asalternativeelectron
acceptors [19, 23]. Transcripts of the nar and nir operon
were found to be present at elevated levels under anaerobic
conditions [19].
Additionally, CT also induced the arcABCD genes, which
are associated with energy metabolism. The S. aureus
arginine deiminase (ADI) metabolic pathway genes are
organizedinanoperonarcABDC [24].Theproteinsencoded
by arcABCD are responsible for the ADI pathway, which
enables arginine-dependent anaerobic growth [25]. Oxygen
deﬁciency promotes the autophosphorylation of ArcB that
activates phosphorylation of ArcA and results in regula-
tion of numerous operons that provide control of carbon
catabolism and cellular redox status [26]. Consequently, our
results described herein imply that CT may induce anaerobic
respiration and fermentation in S. aureus.Journal of Biomedicine and Biotechnology 5
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Figure 1: Growth curve for S. aureus strain ATCC 25923 in the
presence or absence of CT. , S. aureus ATCC 25923 plus 1μg·mL
CT; Δ, S. aureus ATCC 25923 plus 2μg·mL CT; ∗, S. aureus ATCC
25923 plus 4μg·mL CT; , S. aureus ATCC 25923 plus 8μg·mL CT;
, S. aureus ATCC 25923 plus 16μg·mL CT; , untreated S. aureus
ATCC 25923.
Expression of some genes involved in oxidative stress
resistance was aﬀected by CT, including ahpC, ahpF, katA,
and sodM.T h esodM gene encodes superoxide dismutase,
andkatAencodesthecatalaseenzyme.KatA istheonlymajor
catalase in S. aureus, accumulates extracellularly, detoxiﬁes
H2O2,andwasproposedtobeamajorvirulencedeterminant
in S. aureus [27, 28]. Our results showed upregulation of
the katA gene and downregulation of the sodM gene, thus
connecting CT to oxidative-stress response. Surprisingly,
a similar transcriptional response also occurs when cells
are subjected to 1mM peracetic acid [29]. The ahpC gene
encodes alkyl hydroperoxide reductase subunit C, and ahpF
encodes alkyl hydroperoxide reductase subunit F. Our results
also demonstrated an upregulation of the ahpC and ahpF
genes. Alkyl hydroperoxide reductase subunit C (AhpC)
protects cells against OONO2, which is generated within
neutrophils and macrophages [30].
Recent report suggested that superoxide radical forma-
tion might be the cause of antibacterial activity of CT [7].
As mentioned above, our results showed clearly that genes
fdaB, pﬂB, pﬂA, nirB, nirD, narG, narH,a n dnarI involved
in anaerobic respiration and fermentation were upregulated,
and genes ahpC, ahpF,a n dkatA involved in oxidative stress
resistance were upregulated by CT. Chang et al. indicated
that hydrogen peroxide, a reactive oxygen species, led to
genes pﬂBA and arcBC increases in transcription levels; they
suggested that S. aureus might undergo an oxygen-limiting
stateinresponsetohydrogenperoxide-drivenoxidativestress
[31]. Further, previous result showed that in E. coli pﬂ
is signiﬁcantly induced by shifting the culture condition
from an aerobic to a microaerobic state [32]. Moreover,
transcriptome and proteome analysis of Bacillus subtilis
gene expression in response to superoxide and peroxide
stress showed that genes katA and ahpCF were signiﬁcantly
induced [33]. Thus, our microarray result is consistent with
previous observations which revealed that CT might act
as superoxide radicals generator; Lee et al. proposed that
this phenomenon beneﬁted S. aureus by preventing further
cytotoxicity arising from reactive oxygen species produced
during oxygen respiration [7]. Lactoquinomycin A (LQMA),
anantibiotichavingaquinonemoietylikeCT,alsogenerated
superoxide radicals during reduction of the quinone moiety
by quinone reductase and resulted in other active oxygens
[7].
3.5. Antibiotics Resistance Genes Aﬀe c t e db yC T .Genechip
analysis showed that several antibiotic resistance genes were
diﬀerentially regulated by CT exposure, including dfrA,
drp35,cdsA,andpgsA.Amongthese,thetranscriptionofdfrA
was upregulated, whereas the transcription of drp35, pgsA
(−2.0-fold), and cdsA was signiﬁcantly downregulated by CT
exposure. The dfrA gene encodes dihydrofolate reductase,
which is responsible for trimethoprim resistance (Tpr)[ 34].
In present study, we found that CT has high MIC values in
trimethoprimsulfamethoxazole (TMP/SXT) susceptible and
resistant strains. In order to test the interaction between
CT and TMP/SXT, we conducted additional experiment to
assay the vitro antimicrobial activity of CT against S. aureus
strain ATCC 25923 in combination with TMP/SXT using
checkerboard microdilution method. The result showed
that there is an antagonism in combination of CT and
TMP/SXT against S. aureus 25923, with FICI of 4. It is
indicated that the increased expression of gene dfrA induced
by CT might increase the resistance of the S. aureus to
TMP/SXT. This result suggested that it is necessary to
avoid simultanous use of CT and TMP/SXT. The drp35
gene encodes Drp35, which possesses calcium-dependent
lactonase activity and is a cytoplasmic protein induced by
cell wall-aﬀecting antibiotics or detergents [35]. Antibiotic
susceptibility experiments using a drp35-defective strain and
an overexpressing strain of S. aureus revealed that Drp35
is correlated with bacitracin resistance [36]. Two essential
genes,cdsAandpgsA,encodingphosphatidatecytidylyltrans-
ferase and phosphatidylglycerophosphate synthase, respec-
tively, are required for synthesis of phosphatidylglycerol
phosphate, which might be converted into phosphoglycerol
by a nonspeciﬁc phosphatase [37]. Conditional lethal alleles
of genes involved in phospholipid biosynthesis in S. aureus,
including pgsA and cdsA, have also been found to confer
hypersusceptibility to macrolides [38].
3.6. Other Genes Diﬀe r e n t i a l l yR e g u l a t e db yC T .We found
that 2 carotenoid pigment-associated genes, crtM and
crtN,o fS. aureus were upregulated in response to CT.
Carotenoids are natural pigments with important biological
activities [39–41]. The species description of S. aureus
reﬂects the colony color (L. aureus:g o l d e no ro r a n g e )
and distinguishes this species from Staphylococcus epider-
midis (formerly Staphylococcus albus)[ 42]. Additionally, CT
exposure also induced the ald gene that encodes aldehyde
dehydrogenase, which is associated with biosynthesis of C30
carotenoids in S. aureus.T h eald gene was located between
crtN and crtNb in the same gene cluster [43].
Moreover, some putative transporter genes were diﬀer-
entially regulated by CT exposure. In our study, a large
number of putative transporter genes (39) were diﬀerentially
regulated upon exposure to CT; 12 of these genes were6 Journal of Biomedicine and Biotechnology
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Figure 2: CT-responsive genes grouped by functional classiﬁcation. The diﬀerentially regulated genes were divided into 33 functional
categories. The number of genes upregulated and downregulated for each functional group was represented.
Table 3: Real-time RT-PCR analysis of gene expression.
N315 ORF N315 gene N315 description Fold change ± SD(a)
RT-PCR Microarray
SA1587 ribA Riboﬂavin biosynthesis protein −3.8 ±1.9 −2.5 ±1.3
SA0977 isdA Cell surface protein −4.3 ±2.3 −3.2 ±1.0
SA2074 modA Probable molybdate-binding
protein
−2.8 ±0.9 −2.5 ±0.8
SA1648 seo Enterotoxin SeO [Pathogenicity
island SaPIn3]
−3.8 ±1.2 −2.5 ±0.6
SA1831 Hypothetical protein
[Pathogenicity island SaPIn1]
−19.4 ±6.1 −6.1 ±1.6
SA0982 srtB NPQTN speciﬁc sortase B −3.2 ±0.8 −3.0 ±1.1
SA0325 glpT Glycerol-3-phosphate
transporter
−2.7 ±0.3 −2.8 ±0.4
SA0198 oppF Oligopeptide transport
ATP-binding protein
−2.8 ±0.5 −2.5 ±0.8
SA2135 Hypothetical protein, similar to
sodium/glutamate symporter
−2.8 ±0.8 −2.1 ±0.8
SA0206 msmX Multiple sugar-binding transport
ATP-binding protein
−3.4 ±1.0 −2.5 ±0.8
SA2251 opp-1F Oligopeptide transporter
putative ATPase domain
−2.6 ±0.7 −2.6 ±0.6
SA1941 dps General stress protein 20U 10.5 ±2.84 .9 ±1.6
SA0302 Probable pyrimidine nucleoside
transport protein
18.4 ±5.46 .1 ±1.7
(a) + indicates reduction, and − indicates increase. Standard deviation were calculated based on three independent experiments.Journal of Biomedicine and Biotechnology 7
upregulated, while 27 were downregulated. These genes
included 26 ATP-dependent transporter genes (all involved
in the ATP-binding cassette (ABC) superfamily)a n d1 2s e c -
ondary transporter genes (3 genes are associated with
the major facilitator superfamily (MFS)). In addition, a
phosphotransferase system (PTS) gene, mtlA (SA1962), was
expressed at an increased level. Among the putative trans-
porter genes regulated by CT, the semB gene is a multidrug
resistance (MDR) transporter, which was expressed at an
increased level of 2.8-fold.
3.7. Validation of Microarray Data by Real-Time RT-PCR.
Real-time quantitative RT-PCR was conducted to validate
microarray data using the same RNA from the original
microarray experiment, and 13 genes were selected for this
analysis (i.e., ribA, isdA, modA, seo, SA1831, srtB, glpT,
oppF, SA2135, msmX, opp-1F, dps, and SA0302). In general,
there were positive correlations between microarray data
and real-time RT-PCR data for all 13 genes (Table 3).
However, expression of the genes SA1831 and SA0302 was
observedatgreatern-foldchangesbyreal-timeRT-PCRthan
with microarray analysis, indicating that real-time RT-PCR
analysis may be more sensitive to changes than microarray
analysis in transcript levels. For the remaining 11 genes (i.e.,
ribA, isdA, modA, seo, srtB, glpT, oppF, SA2135, msmX, opp-
1F,a n ddps), the levels of gene induction did not diﬀer
markedly between microarray data and real-time RT-PCR
data.
4. Conclusion
In summary, the presented antibacterial activity and growth
curve experiments demonstrated that CT is a bacteriostatic
agent against S. aureus. Transcriptional proﬁling revealed
that the action mechanism of CT on S. aureus is correlated to
its action as active oxygen radical generator; S. aureus might
undergo an oxygen-limiting state upon exposure to CT. To
our knowledge, this genome-wide transcriptomic approach
revealed the ﬁrst insights into the response of S. aureus
to CT challenge. Recognition of CT lays the groundwork
for developing new agents owning good activity based on
chemical structure modiﬁcation of the lead compound.
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